Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PTC Therapeutics
Biotech
Novartis pays PTC $1B upfront for midphase Huntington's program
The biotech has built its case for the oral candidate around evidence it reduces levels of the protein in the central nervous system and periphery.
Nick Paul Taylor
Dec 2, 2024 7:53am
PTC sells priority review voucher from Kebilidi nod for $150M
Nov 27, 2024 8:35am
PTC axes utreloxastat program after phase 2 ALS failure
Nov 27, 2024 4:45am
NJ biopharmas make pledge to give time off for clinical trials
Nov 20, 2024 10:00am
PTC bounces back with positive data on FA prospect vatiquinone
Oct 8, 2024 9:34am
After pair of failures, PTC finds path for Friedreich ataxia med
Mar 1, 2024 9:20am
